Drugs / Limbal epithelial stem cell graft
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02318485 | Apr 2015 → Jan 2023 | limbal stem cell deficiency | University Hospital, Antwerp | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Limbal epithelial stem cell graft | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02318485 ↗ |
| Modality | Cell therapy | “this cell based therapy has the potential to provide this orphan pathology with an effective treatment option” NCT02318485 ↗ |
| Route | Other | “A limbal epithelial stem cell graft will be transplanted onto the limbal stem cell deficient eye” NCT02318485 ↗ |